Platelet chemiluminescence and endothelial dysfunctionin patients with acute myocardial infarction

Authors: Ryzhkova E.V.1, Ryazankina N.B.1, Lebedeva А.M.1, Аlbakova Т.M.1, Аlbakova R.M.1, Gabbasov Z.A.2, Kogan-Yasnyy V.V.3, Shpektor А.V.1, Vasilieva Е.Yu.1

Company: 1Department of Cardiology of Moscow State University of Medicine and Dentistry named after A.I. Evdokimov of Ministry of Health of the Russian Federation; Delegatskaya ulitsa, 20, stroenie 1, Moscow, 127473, Russian Federation;
2Research Institute of Clinical Cardiology of Russian Cardiology Research and Production Complex of Ministry of Health of the Russian Federation; ulitsa 3-ya Cherepkovskaya, 15a, Moscow, 121552, Russian Federation;
Independent researcher

For correspondence:  Sign in or register.


For citation: Ryzhkova E.V., Ryazankina N.B., Lebedeva А.M., Аlbakova Т.M., Аlbakova R.M., Gabbasov Z.A., Kogan-Yasnyy V.V., Shpektor А.V., Vasilieva Е.Yu.. Platelet chemiluminescence and endothelial dysfunction in patients with acute myocardial infarction. Kreativnaya Kardiologiya. 2016; 10 (3): 195-200 (in Russian)

Keywords: platelets chemiluminescence endothelial dysfunction myocardial infarction

Полнотекстовая версия:  



Objective. Previously it was demonstrated that in patients with coronary artery disease (CAD) platelets are potent  reactive oxygen species (ROS) producers. Luminol-enhanced chemiluminescence (LEC) can detect ROS generated  by platelets. The aim of this study was to evaluate endothelial function and platelets' ROS production in acute  myocardial infarction (AMI).

Material and methods. 50 AMI patients and 18 patients without CAD were enrolled in the study. In patients we measured luminol-enhanced chemiluminescence (LEC). Endothelial function was assessed by means of flowmediated dilation (FMD) test. The plasma level of the high-sensitivity C-reactive protein (hsCRP) was estimated as the marker of systemic inflammation.

Results. In AMI patients on the first day of admission we found a moderate negative correlation between levels of LEC and FMD (Spearman ρ = –0,44; р = 0,001). In patients without CAD, no significant correlations between levels of LEC, FMD, and hsCRP were revealed.

Conclusions. In our study we showed that in AMI patients on the first day of admission ROS production by platelets as evaluated from LEC is associated with severity of endothelial dysfunction.


  1. Mann D., Zipes D., Libby P., Bonow R.O. (eds). Braunwald's heart disease: a textbook of cardiovascular medicine. 10th ed. Saunders-Elseiver; 2014.
  2. Gawaz M., Langer H., May A.E. Platelets in inflammation and atherogenesis. J. Clin. Invest. 2005; 115 (12): 3378–84.
  3. Brevetti G., Silvestro A., Schiano V., Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation. 2003; 108: 2093–8.
  4. Halcox J.P., Schenke W.H., Zalos G. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002; 106: 653–8.
  5. Herter J.M., Rossaint J., Zarbock A. Platelets in inflammation and immunity. J. Thromb. Haemost. 2014; 12 (11): 1764–75.
  6. Jenne C.N., Urrutia R., Kubes P. Platelets: bridging hemostasis, inflammation, and immunity. Int. J. Lab. Hematol. 2013; 35: 254–61.
  7. Ferrer-Acosta Y., González M., Fernández M., Washington A.V. Emerging roles for platelets in inflammation and disease. J. Infect. Dis. Ther. 2014; 2: 149.
  8. Schrottmaier C., Kral J.B., Badrnya S., Assinger A. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes. Thromb. Haemost. 2015; 114 (3): 478–89.
  9. Zimmerman G.A., McIntyre T.M., Prescott S.M., Stafforini D.M. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit. Care Med. 2002; 30: 294–301.
  10. Gabbasov Z., Ivanova O., Kogan-Yasny V., Vasilieva E. Aspirin can stimulate luminol-enhanced chemiluminescence of activated. Platelets. 2010; 21 (6): 486–9.
  11. Gabbasov Z., Ivanova O., Kogan-Yasny V., Ryzhkova E. et al. Activated platelet chemiluminescence and presence of CD45+ platelets in patients with acute myocardial infarction. Platelets. 2014; 25 (6): 405–8.
  12. Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D. et al. Third universal definition of myocardial infarction. Eur. Heart J. 2012; 33: 2551–67.
  13. Flammer A.J., Anderson T., Celermajer D.S., Creager M.A., Deanfield J., Ganz P. et al. The assessment of endothelial function from research into clinical practice. Circulation. 2012; 126: 753–67.
  14. Montezano A.C., Touyz R.M. Reactive oxygen species and endothelial function – role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. Basic Clin. Pharmacol. Toxicol. 2012; 110 (1): 87–94.
  15. De Pascali F., Hemann C., Samons K., Chen C.-A., Zweier J.L. Hypoxia and reoxygenation induce endothelial nitric oxide synthase uncoupling in endothelial cells through tetrahydrobiopterin depletion and S-glutathionylation. Biochemistry. 2014; 53: 3679–88.
  16. Touyz R.M., Tabet F., Schiffrin E.L. Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin. Exp. Pharmacol. Physiol. 2003; 30: 860–6.
  17. Gutierrez J., Ballinger S.W., Darley-Usmar V.M., Landar A. Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ. Res. 2006; 99: 924–32.
  18. Wachowicz B., Olas B., Zbikowska H.M., Buczynski A. Generation of reactive oxygen species in blood platelets. Platelets. 2002; 13: 175–82.

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, Director of Bakoulev National Medical Research Center for Cardiovascular Surgery